Boston An independent LDT provider

Press releases

March 29, 2021 | REGULATORY

Immunovia reports improved test performance of IMMray[TM] PanCan-d in detecting early stage pancreatic cancer in high risk symptomatic patients

Read press release
March 12, 2021 | REGULATORY

Immunovia publishes the annual report for the financial year 2020

Read press release
February 26, 2021

Immunovia publishes data sets on the Optimization Study and Commercial Test Model Study

Read press release
February 17, 2021 | REGULATORY

Immunovia Full Year Report 2020

Read press release
February 15, 2021

Immunovia’s PanFAM-1 Prospective Study Gathers Over 3000 Familial Hereditary Pancreatic Cancer Risk Samples And Will Be Analysed In The Second Half Of 2021

Read press release
February 11, 2021

Invitation to presentation of Immunovia’s Full Year Report 2020 on February 17, 2021

Read press release
February 10, 2021

Immunovia On Track For IMMray™ PanCan-d Sales Start In Q1 2021

Read press release
January 19, 2021

Chief Executive Officer, Patrik Dahlen Buys Immunovia Warrants

Read press release
January 7, 2021

Proteomic data derived from Immunovia’s IMMray™-platform allows differential diagnosis of difficult to distinguish autoimmune diseases

Read press release
December 14, 2020

Immunovia publishes link to Webinar No. 3 on IMMray™ PanCan-d: Verification Study and Clinical Use

Read press release
December 11, 2020

Immunovia to Host a Third Webinar in the Series on IMMray™ PanCan-d: Verification Study and Clinical Use

Read press release
December 7, 2020

Immunovia Announces Investor Relations Changes

Read press release
1 3 4 5 6 7 22